Data as of May 24
| +1.26 / +17.70%|
The 4 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 8.50, with a high estimate of 17.00 and a low estimate of 7.00. The median estimate represents a +1.43% increase from the last price of 8.38.
The current consensus among 5 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.